Scientists continue studying how hemp-derived cannabinoids may support the body’s response to neuroinflammation and neurodegenerative conditions. In the review “Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration,” researchers examined how cannabinoids such as CBD, CBG, and CBC interact with microglia — the immune cells of the central nervous […]
Category: CBD
Cannabis-Derived Compounds Reduce Inflammation Through Multiple Biological Pathways (Pub May 2022)
Inflammation plays a central role in many chronic health conditions, and a 2022 scientific review examined how cannabinoids found in medical cannabis may help regulate inflammatory responses throughout the body. The authors reviewed evidence on major cannabinoids including CBD, THC, CBG, CBC, and CBN, highlighting their ability to interact with the endocannabinoid system and other […]
CBD and CBG Demonstrate Antimicrobial Activity While Preserving Healthy Skin Microbiota (pub. Jan 2023)
A 2023 study examined the antimicrobial effects of cannabidiol (CBD) and cannabigerol (CBG) against bacteria commonly associated with skin conditions and infections. Researchers found that both cannabinoids were active against multiple bacterial species and biofilms, which are protective layers that make bacteria more resistant to treatment. The study also showed that CBD and CBG could […]